L26/O-133 Beyond developmental milestones: maximum expansion and contraction dynamics as euploidy markers in 1,770 PGT-A blastocysts
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J. Fraire-Zamora und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do maximum expansion or contraction dynamics predict euploidy independent of static blastocyst developmental milestones? Summary answer Only maximum blastocyst diameter predicted euploidy independent of developmental timing, while contraction dynamics were not associated to ploidy status. What is known already Faster-developing embryos have been associated with higher euploidy rates, yet standard morphokinetics of euploid and aneuploid embryos have been shown to substantially overlap, limiting their discriminatory value. Most morphokinetic parameters, including cleavage and blastulation events, describe when milestones occur and are statistically intercorrelated as they are influenced by overall developmental progression. Maximum blastocyst diameter and contraction dynamics, measured at hours post insemination (hpi), have been proposed as novel independent markers of developmental competent embryos. Identifying new parameters that can reflect developmental competence rather than developmental intercorrelation is essential for refining embryo selection strategies. Study design, size, duration Retrospective cohort study of 1,779 blastocysts from 450 patients across 496 preimplantation genetic testing for aneuploidies (PGT-A) cycles, conducted between 2019 and 2024 at a single IVF center. PGT-A was performed using TE biopsy and next generation sequencing. All embryos were cultured in timelapse incubators and biopsied on either Day 5 (n = 1,048) or Day 6 (n = 474). Only euploid and aneuploid diagnoses were included. Embryos derived from both autologous (n = 1,707) and donor (n = 72) oocytes were assessed. Participants/materials, setting, methods Maximum blastocyst diameter was measured using bounding-box calculations from AI timelapse sequences. Contraction parameters included: number and timing of sequential contractions and maximum contraction amplitude. Mixed-effects logistic regression, with a random intercept per patient and adjusting for maternal age and donor oocyte status, was used to assess associations with euploidy. Day-stratified adjusted analyses (day 5 vs day 6) and combined analyses (adjusting for biopsy day) were performed. All parameters were annotated by an AI model. Main results and the role of chance Mean maternal age was 38.8(±4.4) years, with an overall euploidy rate of 36.9%. Day 5 blastocysts had higher euploidy rates than day 6 embryos (40.1% vs 31.7%, p = 0.004). Euploid blastocysts achieved larger maximum diameters than aneuploid embryos (161.2±21.9μm vs 154.2±21.6μm, p < 0.001) with a mean time for maximum diameter at 115.3(±26.2) hpi. Diameter at fixed developmental milestones (tSB, tEB) was not associated with euploidy (all p > 0.05). Instead, in day-stratified adjusted analyses, each 10μm increase in maximum blastocyst diameter was associated with a 17% increase in odds of euploidy in day 5 embryos (OR = 1.17, [95%CI: 1.08-1.28], p < 0. 001) and 11% in day 6 embryos (OR = 1.11, [95%CI: 1.02-1.20], p = 0.015). Critically, this association persisted in combined adjusted analyses (OR = 1.14, [95%CI: 1.07-1.21], p < 0.001), suggesting that blastocysts with larger maximum expansion diameters are more likely to be euploid. Earlier first blastocyst contraction times were slightly associated with euploidy in day 5 embryos (OR = 0.97, [95%CI: 0.95-1.00], p = 0.041), however this did not persist after adjusting for biopsy day (p = 0.134). Neither number of contractions, subsequent contraction timings, or maximum contraction amplitude were associated with euploidy (all p > 0.05). Limitations, reasons for caution The retrospective, single-center design may limit causal inference and generalizability. Importantly, euploidy was the primary endpoint. The ability of maximum blastocyst diameter to predict pregnancy or live birth from euploid embryos, warrants further prospective evaluation. Wider implications of the findings Our findings suggest that maximum blastocyst diameter can reflect embryos ploidy status and that maximum blastocyst expansion could be considered as a relevant biomarker for AI-based algorithms and selection tools. As clinical focus shifts from identifying to ranking euploid embryos, functional markers may prove essential for embryo developmental competence predictions. Trial registration number No
Zitieren
APA
Fraire-Zamora, J., Escalada, I. M., Zamora, M., Rodríguez-Aranda, A., Kelley, K., Wiemer, K., Ben-Meir, A., & Pini, P. (2026). L26/O-133 Beyond developmental milestones: maximum expansion and contraction dynamics as euploidy markers in 1,770 PGT-A blastocysts. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.133
Vancouver
Fraire-Zamora J, Escalada IM, Zamora M, Rodríguez-Aranda A, Kelley K, Wiemer K, et al. L26/O-133 Beyond developmental milestones: maximum expansion and contraction dynamics as euploidy markers in 1,770 PGT-A blastocysts. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.133
BibTeX
@article{FraireZamora2026,
author = {Fraire-Zamora, J. and Escalada, I. Miguel and Zamora, M.J. and Rodríguez-Aranda, A. and Kelley, K. and Wiemer, K. and Ben-Meir, A. and Pini, P.},
title = {L26/O-133 Beyond developmental milestones: maximum expansion and contraction dynamics as euploidy markers in 1,770 PGT-A blastocysts},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.133}
}
EUVIMED